Marksans Pharma Q4 FY 26 Earnings Call Transcript Now on NSE
Marksans Pharma has published the transcript of its Q4 FY 26 earnings conference call with analysts on NSE, covering the company's audited financial results for the quarter.
Read articleAI-assisted articles on quarterly results, exchange filings, and earnings calls — tied to the companies you follow.
6 articles published
Results for “MARKSANS” · in Market Updates — Clear filters
Marksans Pharma has published the transcript of its Q4 FY 26 earnings conference call with analysts on NSE, covering the company's audited financial results for the quarter.
Read articleMarksans Pharma has made its Q4 FY26 investor call transcript available via NSE filing. The document covers the audited financial results presentation to analysts and institutional investors.
Read articleAnalysts/Institutional Investor Meet/Con. Call Updates Marksans Pharma Limited has informed the Exchange about Transcript of Investors/Analyst meet on Q4 FY 26 Audited Financial Results Marksans Pharma Limited has informed the Exchange about Transcript of Investors/Analyst meet on Q4 FY 26 Audited Financial Results Marksans Pharma Limited has informed the Exchange about Transcript of Investors/Analyst meet on Q4 FY 26 Audited Financial Results Marksans Pharma Limited has informed the Exchang
Read articleMarksans Pharma has initiated a shareholder engagement campaign urging investors to complete KYC updations and claim pending dividends before these are transferred to the Investor Education and Protection Fund (IEPF).
Read articleCompany Update Campaign for KYC and other related updations and shareholders engagement to prevent transfer of unclaimed dividend to IEPF Campaign for KYC and other related updations and shareholders engagement to prevent transfer of unclaimed dividend to IEPF Campaign for KYC and other related updations and shareholders engagement to prevent transfer of unclaimed dividend to IEPF
Read articlePress Release Marksans Pharma Limited has informed the Exchange regarding a press release dated Jun 01, 2026, titled "Marksans Pharma to Acquire 100% of Netherlands-based QliniQ B.V., Strengthening Presence in European Markets". Marksans Pharma Limited has informed the Exchange regarding a press release dated Jun 01, 2026, titled "Marksans Pharma to Acquire 100% of Netherlands-based QliniQ B.V., Strengthening Presence in European Markets". Marksans Pharma Limited has informed the Exchange reg
Read articleNSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.
Filings and alerts in WhatsApp or Telegram
Focus on news that matter most to you
Track 5 companies at no cost. Upgrade anytime.